These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recent Advances in Theranostic Applications of Nanomaterials in Cancer. Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703 [TBL] [Abstract][Full Text] [Related]
6. Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects. Sajjadi M; Nasrollahzadeh M; Jaleh B; Soufi GJ; Iravani S J Drug Target; 2021 Aug; 29(7):716-741. PubMed ID: 33566719 [TBL] [Abstract][Full Text] [Related]
7. Alginate-Based Micro- and Nanosystems for Targeted Cancer Therapy. Iravani S; Varma RS Mar Drugs; 2022 Sep; 20(10):. PubMed ID: 36286422 [TBL] [Abstract][Full Text] [Related]
8. Trend in biodegradable porous nanomaterials for anticancer drug delivery. Le BQG; Doan TLH Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1874. PubMed ID: 36597015 [TBL] [Abstract][Full Text] [Related]
9. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives. Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211 [TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanomedicine platforms for cancer therapy. Zhang H J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341 [TBL] [Abstract][Full Text] [Related]
11. Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy. Mohajer F; Ziarani GM; Badiei A; Iravani S; Varma RS Micromachines (Basel); 2022 Oct; 13(10):. PubMed ID: 36296126 [TBL] [Abstract][Full Text] [Related]
12. State of the Art and Perspectives on the Biofunctionalization of Fluorescent Metal Nanoclusters and Carbon Quantum Dots for Targeted Imaging and Drug Delivery. Kundu S; Ghosh M; Sarkar N Langmuir; 2021 Aug; 37(31):9281-9301. PubMed ID: 34297580 [TBL] [Abstract][Full Text] [Related]
13. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Zhang XQ; Xu X; Bertrand N; Pridgen E; Swami A; Farokhzad OC Adv Drug Deliv Rev; 2012 Oct; 64(13):1363-84. PubMed ID: 22917779 [TBL] [Abstract][Full Text] [Related]
14. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. Liu J; Dong J; Zhang T; Peng Q J Control Release; 2018 Sep; 286():64-73. PubMed ID: 30031155 [TBL] [Abstract][Full Text] [Related]
15. Progress in Self-assembling Peptide-based Nanomaterials for Biomedical Applications. Yu CY; Huang W; Li ZP; Lei XY; He DX; Sun L Curr Top Med Chem; 2016; 16(3):281-90. PubMed ID: 26126914 [TBL] [Abstract][Full Text] [Related]
18. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment. Lee JJ; Saiful Yazan L; Che Abdullah CA Int J Nanomedicine; 2017; 12():2373-2384. PubMed ID: 28392694 [TBL] [Abstract][Full Text] [Related]
19. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs. Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781 [TBL] [Abstract][Full Text] [Related]
20. Recent advancements in two-dimensional nanomaterials for drug delivery. Mei X; Hu T; Wang Y; Weng X; Liang R; Wei M Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1596. PubMed ID: 31650709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]